Venezuela will be the first foreign state to use Epivaccorona for vaccination against the coronavirus infection. According to the company, supplies will start in September.
This purchase brings the European Commission’s confirmed order commitment to 460 million doses. Delivery of Moderna’s updated variant booster vaccine candidate will begin in 2022.
The Kremlin spokesman emphasized that respective Russian agencies carry out the toughest control over complying with all requirements for producing COVID-19 vaccines.
Avifavir® became the world’s first approved favipiravir-based drug for COVID-19 infection treatment and the first drug against COVID-19 authorized in Russia.
Via the Russian Direct Investment Fund, the authorities established a mechanism for using foreign sites, where the substance for the production of vaccines is sent to, the minister said.